close
Respiratory Diagnostics
Respiratory Diagnostics

Diagnose, monitor and manage patients’ respiratory health in the most efficient and effective way possible.

Technical Support
Hygiene & Cleaning
Product Registration
Devices
Spirometry Pulmonary Function Testing Respiratory Muscle Strength Complementary Diagnostics Respiratory Monitoring & Screening Bacterial Viral Filters
Solutions
V-Core Flowhead Technology VitaloPFT Office Diagnostics Clinic Diagnostics Hospital Diagnostics
Clinical Trials
Clinical Trials

Custom solutions and a personalized approach mean we can meet a wide range of respiratory clinical study needs.

Clinical Trial Services
Case Studies
Expertise
Respiratory Expertise Cough Studies Asthma Studies COPD studies Cystic fibrosis studies ALS Studies Interstitial lung disease
Solutions
Clinical Endpoint Solutions Respiratory in-clinic Cough monitoring Home monitoring Study centralization Cardiac safety
Resources
Training
On-demand devices & software training Tailored device & software training Spirometry workshops
Education
Respiratory Insights Clinical Trial Insights Webinars
Clinical Library
Reference Papers Clinical Practice Guidelines Whitepapers Lung Function Reference Values
News & Insights
Vital Insights

The latest respiratory news including clinical research, articles on respiratory topics, patient information pieces, and episodes of our ever popular Exhale podcast.

Insights
Respiratory Insights Clinical Trial Insights Exhale Podcast At Vitalograph
News & Events
News Events
About
About

Vitalograph products and services are chosen by medical professionals in over 113 countries for healthcare, occupational health, and clinical trials.

Company Careers Sustainability Philanthropy At Vitalograph
Contact
contact_support
menu
Contact
Home / Tag

VitaloJAK

Reference Papers
Efficacy of oral nalbuphine extended release for the treatment of chronic cough in idiopathic pulmonary fibrosis: Analysis of a Phase 2 study
Read More
Reference Papers
Validation and meaningful change thresholds for an objective cough frequency measurement in chronic cough
Read More
Reference Papers
Evaluation of nocturnal asthma control (NAC-Study) in children with (partially) controlled asthma: Comparative analysis of subjective and objective measurements
Read More
Reference Papers
Treatment with the P2X3-receptor antagonist gefapixant for acute cough in induced viral upper respiratory tract infection: A Phase 2a, randomized, placebo-controlled trial
Read More
Reference Papers
Improvements in objective and subjective measures of chronic cough with gefapixant: A pooled Phase 3 efficacy analysis of predefined subgroups
Read More
Reference Papers
Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough
Read More
Reference Papers
Safety, pharmacodynamics, and pharmacokinetics of P2X3 receptor antagonist eliapixant (BAY 1817080) in healthy subjects: Double-blind randomized study
Read More
Reference Papers
The novel bronchodilator navafenterol: A Phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
Read More
Reference Papers
Effect of traffic-related air pollution on cough in adults with polymorphisms in several cough-related genes
Read More
Reference Papers
Demographic, clinical, and patient-reported outcome data from two global, Phase 3 trials of chronic cough
Read More
Reference Papers
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): Results from two double-blind, randomised, parallel-grou
Read More
Reference Papers
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
Read More